Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114812) titled 'Losartan Combined with Lenvatinib for Postoperative Adjuvant Therapy in Patients with Tumor Budding-Positive Hepatocellular Carcinoma: A Multicenter, Prospective, Single-Arm Trial' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
Condition:
tumor budding positive hepatocellular carcinoma
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-01-27
Target Sample Size: Lenvatinib+losartan treatment group:56;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sh...